Epstein Secrets

efense Secretary Jim Mattis about helping him with the transition and possibly serving in the new administration. (Politico) • Donald Trump Jr. and Eric Trump are gung-ho about their dad fighting to the bitter end while Ivanka Trump "has emerged as someone looking for a way for the President to save face,

dministration. (Politico) • Donald Trump Jr. and Eric Trump are gung-ho about their dad fighting to th

ur Sahin, chief executive of the German medical start-up BioNTech, had been anxiously EFTA00162637 awaiting. `Are you sitting down?' Pfizer chief Albert Bourla asked him. The news that followed was better than Sahin had hoped: Preliminary analysis from Phase 3 trials of his company's coronavirus vaccine sh

continuing coverage about the investigation into Eric Breemen, who "is accused of hitting [Lakhwant] S

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

continuing coverage about the investigation into Eric Breemen, who "is accused of hitting [Lakhwant] S

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

ttee voted Thursday to advance the nomination of Eric Lander, President Biden's nominee to lead the Whi

that while the latest data is encouraging, new data also shows that Americans may need a booster shot against COVID in the future. Pfizer Chair/CEO Albert Bourla said in remarks on Wednesday, "There will be a need for a booster somewhere between eight and twelve months." COVID Caused US Mortality Rate To Sur

continuing coverage about the investigation into Eric Breemen, who "is accused of hitting [Lakhwant] S

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U

continuing coverage about the investigation into Eric Breemen, who "is accused of hitting [Lakhwant) S

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U